Changes in serial B-type natriuretic peptide level independently predict cardiac allograft rejection

Journal of Heart and Lung Transplantation

Volumn 31, Issue 7, 2012, Pages 708-714

  Damodaran, Arun ^a   Dardas, Todd ^b   Wu, Audrey H ^c   Dyke, David B S ^c   Hummel, Scott L ^c,d   Cowger, Jennifer A ^c   Koelling, Todd M ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

biological markers; biopsy; BNP (B type natriuretic peptide); graft rejection; heart transplantation; natriuretic peptides

Indexed keywords

AZATHIOPRINE; BRAIN NATRIURETIC PEPTIDE; CALCINEURIN INHIBITOR; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HEART HEMODYNAMICS; HEART MUSCLE BIOPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BIOPSY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84861894446     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.02.014     Document Type: Article

References (19)

1. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: twentyeighth adult heart transplant report-2011. J Heart Lung Transplant 2011;30:1078-94.
2. Stehlik J, Starling RC, Movsesian MA, et al. Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis. J Heart Lung Transplant 2006;25:1402-9. (Pubitemid 44909475)
3. Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med 2010;362:1890-900.
4. Costanzo MR, Dipchand A, Starling R, et al. The International Society for Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010;29:914-56.
5. Deng MC, Eisen HJ, Mehra MR, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006;6:150-60. (Pubitemid 43382213)
6. Masters RG, Davies RA, Veinot JP, et al. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 1999;100:287-91. (Pubitemid 29340136)
7. Park MH, Scott RL, Uber PA, et al. Bedside B-type natriuretic peptide and acute non-cellular cardiac allograft rejection. J Heart Lung Transplant 2002;21:613-4. (Pubitemid 34451038)
8. Almenar L, Hervás I, Martínez-Dolz L, et al. The value of brain natriuretic peptide for the diagnosis of heart transplant rejection. Transplant Proc 2002;34:174-5. (Pubitemid 34311620)
9. Wu AH, Johnson ML, Aaronson KD, et al. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements. J Heart Lung Transplant 2005;24:52-7. (Pubitemid 40093992)
10. Cuppoletti A, Roig E, Pérez-Villa F, et al. Value of NT-proBNP determinations in the follow-up of heart transplantation. Transplant Proc 2005;37:4033-5. (Pubitemid 43015246)
11. Garrido IP, Pascual-Figal DA, Nicolás F, et al. Usefulness of serial monitoring of B-type natriuretic peptide for the detection of acute rejection after heart transplantation. Am J Cardiol 2009;103: 1149-53.
12. Kittleson MM, Skojec DV, Wittstein IS, et al. The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients. J Heart Lung Transplant 2009;28:704-9.
13. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 1990;9:587-93.
14. Susan S, Gayle LW, Michael CF, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24:1710-20.
15. Wu AH, Packer M, Smith A, et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004;50:867-73. (Pubitemid 38543665)
16. Hervas I, Arnau MA, Almenar L, et al. Ventricular natriuretic peptide (BNP) in heart transplantation: BNP correlation with endomyocardial biopsy, laboratory and hemodynamic measures. Lab Invest 2004;84: 138-45. (Pubitemid 41656443)
17. Bader FM, Rogers RK, Kfoury AG, et al. Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function. Congest Heart Fail 2009;15:63-7.
18. Shihab FS Waid TH, Conti DJ, et al. Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study. Transplantation 2008;85: 1261-9.
19. Kirklin JK, Naftel DC, Bourge RC, et al. Rejection after cardiac transplantation. A time-related risk factor analysis. Circulation 1992; 86(suppl II):II-236-41.